These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27355513)

  • 1. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
    Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
    PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Communication: SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort.
    Williams B; Livak B; Bahk M; Keating SM; Adeyemi OM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):144-7. PubMed ID: 26366931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals.
    Kooij KW; Wit FW; Booiman T; van der Valk M; Schim van der Loeff MF; Kootstra NA; Reiss P;
    J Infect Dis; 2016 Dec; 214(12):1817-1821. PubMed ID: 27683822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
    Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
    J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
    HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.
    Rusu CC; Racasan S; Kacso IM; Ghervan L; Moldovan D; Potra A; Patiu IM; Bondor C; Caprioara MG
    Int Urol Nephrol; 2015 Dec; 47(12):2023-30. PubMed ID: 26433887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.
    Beltrán LM; Muñoz Hernández R; de Pablo Bernal RS; García Morillo JS; Egido J; Noval ML; Ferrando-Martinez S; Blanco-Colio LM; Genebat M; Villar JR; Moreno-Luna R; Moreno JA
    PLoS One; 2014; 9(3):e90541. PubMed ID: 24594990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
    Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
    AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People.
    Sunil M; Nigalye M; Somasunderam A; Martinez ML; Yu X; Arduino RC; Utay NS; Bell TK
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1205-1209. PubMed ID: 27344921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis.
    Jude C; Dejica D; Samasca G; Balacescu L; Balacescu O
    Rheumatol Int; 2013 Apr; 33(4):1031-7. PubMed ID: 23011084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis.
    Sun H; Jiang R; Han B; Du X; Ma C; Xu Y; Chen Z; Wang L; Yang S; Lv X; Zhao H; Li X
    J Infect Dev Ctries; 2019 Aug; 13(8):714-719. PubMed ID: 32069255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.
    D'Antoni ML; Byron MM; Chan P; Sailasuta N; Sacdalan C; Sithinamsuwan P; Tipsuk S; Pinyakorn S; Kroon E; Slike BM; Krebs SJ; Khadka VS; Chalermchai T; Kallianpur KJ; Robb M; Spudich S; Valcour V; Ananworanich J; Ndhlovu LC;
    J Infect Dis; 2018 Sep; 218(9):1453-1463. PubMed ID: 29868826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
    Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans.
    Letizia A; Eller MA; Polyak C; Eller LA; Creegan M; Dawson P; Bryant C; D K; Crowell TA; Lombardi K; Rono E; Robb ML; Michael NL; Maswai J; Ake JA
    J Infect Dis; 2019 Jan; 219(2):284-294. PubMed ID: 30165548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.
    Brusca RM; Hanna DB; Wada NI; Blankson JN; Witt MD; Jacobson LP; Kingsley L; Palella FJ; Budoff M; Brown TT; Anastos K; Lazar JM; Mack WJ; Bacchetti P; Tien PC; Golzar Y; Plankey M; Golub E; Kaplan RC; Post WS
    HIV Med; 2020 Apr; 21(4):217-227. PubMed ID: 31729142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.
    Fitch KV; Srinivasa S; Abbara S; Burdo TH; Williams KC; Eneh P; Lo J; Grinspoon SK
    J Infect Dis; 2013 Dec; 208(11):1737-46. PubMed ID: 24041790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.